Marie Hjelm-Eriksson
Papers
1
Total Citations
33
H-Index
1
About
Marie Hjelm-Eriksson is a leading clinical researcher in prostate cancer survivorship, focusing on the long-term functional and psychological outcomes of curative treatments. Her major contributions center on large-scale, population-based studies that provide unselected, real-world data on patient-reported side effects. Her landmark 2024 nationwide register-based study, cited 33 times, systematically assessed urinary symptoms, bowel disturbances, erectile dysfunction, and quality of life one year after radical prostatectomy or radiotherapy, filling a critical gap in contemporary evidence. By leveraging comprehensive national registries, Hjelm-Eriksson’s work offers clinicians and patients robust, actionable insights into treatment trade-offs, directly informing shared decision-making. Her research is distinguished by its methodological rigor and patient-centered focus, capturing the lived experiences of thousands of men. This impactful study has become a key reference for urologists and oncologists, underscoring her role in advancing evidence-based survivorship care. Hjelm-Eriksson’s ongoing contributions continue to shape guidelines and improve quality of life for prostate cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1